Back to KPTI
MARSHALL WACE, LLP KPTI Position History
Karyopharm Therapeutics Inc.
Quarters held
29
Latest value
$878K
Q2 2026
Peak value
$5.5M
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $2.2M |
| Q1 2023 | $5.5M |
| Q2 2023 | $1M |
| Q2 2023 | $3.3M |
| Q3 2023 | $775K |
| Q3 2023 | $2.2M |
| Q4 2023 | $497K |
| Q4 2023 | $1.2M |
| Q1 2024 | $873K |
| Q1 2024 | $3M |
| Q2 2024 | $503K |
| Q2 2024 | $1.7M |
| Q3 2024 | $497K |
| Q3 2024 | $1.2M |
| Q4 2024 | $917K |
| Q4 2024 | $397K |
| Q4 2024 | $318K |
| Q1 2025 | $144K |
| Q1 2025 | $336K |
| Q2 2025 | $166K |
| Q2 2025 | $388K |
| Q3 2025 | $252K |
| Q3 2025 | $588K |
| Q4 2025 | $284K |
| Q4 2025 | $662K |
| Q1 2026 | $215K |
| Q1 2026 | $501K |
| Q2 2026 | $376K |
| Q2 2026 | $878K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $878K | 89.9K | — | — |
| Q2 2026 | $376K | 38.5K | — | — |
| Q1 2026 | $501K | 89.9K | — | — |
| Q1 2026 | $215K | 38.5K | — | — |
| Q4 2025 | $662K | 89.9K | — | — |
| Q4 2025 | $284K | 38.5K | — | — |
| Q3 2025 | $588K | 89.9K | — | — |
| Q3 2025 | $252K | 38.5K | — | — |
| Q2 2025 | $388K | 89.9K | — | — |
| Q2 2025 | $166K | 38.5K | — | — |
| Q1 2025 | $336K | 89.9K | — | — |
| Q1 2025 | $144K | 38.5K | — | — |
| Q4 2024 | $318K | 468.3K | — | — |
| Q4 2024 | $397K | 584.3K | — | — |
| Q4 2024 | $917K | 1.35M | — | — |
| Q3 2024 | $1.2M | 1.48M | — | — |
| Q3 2024 | $497K | 598.3K | — | — |
| Q2 2024 | $1.7M | 2.00M | — | — |
| Q2 2024 | $503K | 578.0K | — | — |
| Q1 2024 | $3M | 2.02M | — | — |
| Q1 2024 | $873K | 578.0K | — | — |
| Q4 2023 | $1.2M | 1.35M | — | — |
| Q4 2023 | $497K | 578.0K | — | — |
| Q3 2023 | $2.2M | 1.61M | — | — |
| Q3 2023 | $775K | 578.0K | — | — |
| Q2 2023 | $3.3M | 1.87M | — | — |
| Q2 2023 | $1M | 578.0K | — | — |
| Q1 2023 | $5.5M | 1.41M | — | — |
| Q1 2023 | $2.2M | 578.0K | — | — |